TrialInternational journal of clinical oncology2020

Phase II clinical trial of gemcitabine plus oxaliplatin in patients with metastatic pancreatic adenocarcinoma with a family history of pancreatic/breast/ovarian/prostate cancer or personal history of breast/ovarian/prostate cancer (FABRIC study).

Naohiro Okano et al.PubMed ↗Publisher ↗

No numbers read from the abstract.